Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUTONOMY: Lispro Titration in Type 2 Diabetes Mellitus
NCT01215955Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2010
- Primary completion
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 15
01
Overview
A Phase 4 trial of human insulin in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Dec 2010; status: completed.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01215955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01215955.